# A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

> **NCT04802746** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 78 (actual)

## Conditions studied

- Healthy Study Participants
- Participants With Mild Asthma

## Interventions

- **DRUG:** Alprazolam
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04802746
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2021-11-22
- **Final completion:** 2021-11-22
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04802746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04802746, "A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04802746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*